Publication | Open Access

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial

VaccinationVaccine SafetyVaccine DevelopmentPhase 4ImmunologySecond BoosterAerosolised Ad5-ncovMedicineVaccine ResearchCovid-19